From the newsletter
Three healthcare technology startups received a total of $1.8 million in funding in the month of March. This is the lowest monthly funding recorded since January 2026. In January, three companies raised a total of $3.5 million while in February, seven companies raised a total of $3.4 million to expand various digital health services.
Turaco received the highest amount of funding in this round with $1.3 million to expand its health insurance platform, followed by BioVana with $0.3 million for biobanking infrastructure and Revna Biosciences with $0.2 million for biomedical research and clinical services.
Two of these companies are based in West Africa: Revna Biosciences in Ghana and BioVana in Nigeria. Turaco is based in Kenya and represents East Africa.
More details
All three funded startups are led by male CEOs. Turaco has a male-only founding team, while BioVana and Revna Biosciences have mixed-gender founding teams. Despite this diversity at founder level, executive leadership across all three companies remains male-led.
Revna Biosciences, based in Ghana, is a precision medicine and biomedical research company providing advanced clinical diagnostics, genomic testing, pharmacogenetics, biobanking and clinical trial support services. Its work focuses on enabling globally recognised research and personalised healthcare solutions tailored to African populations and international scientific standards.
The company recently received $0.2 million in the March funding round to strengthen its precision medicine capabilities and expand clinical research services. This investment supports its role in advancing high-quality biomedical research and improving diagnostic accuracy in Africa.
BioVana, based in Nigeria, is a health data infrastructure company building connected ecosystems of biobanks and research networks to transform African clinical data into globally trusted datasets for precision medicine. The company received $0.3 million in funding to strengthen its data platforms and scale infrastructure supporting ethical biomedical research across Africa.
Turaco, a Kenya-based on-demand health insurance company, raised $1.3 million in equity funding to expand access to flexible, affordable health coverage. The funding will support growth of its platform and operations, helping scale insurance solutions for underserved populations and strengthening financial protection in healthcare across East Africa.
Our take
March’s drop in healthcare funding signals a clear slowdown in investor momentum after a strong start to the year. While not yet a trend, the sharp decline suggests growing caution among investors.
If sustained, this could constrain early-stage innovation and delay the scaling of critical health solutions across Africa’s rapidly evolving healthcare market.